Bio Break: How Nature-Inspired Biosensors Are Revolutionizing Medical Devices
In this episode of Bio Break, Nick and Joris dive into the fascinating realm of biosensors, showcasing how nature’s biological processes inspire groundbreaking innovations in medical device technology. From jellyfish to fireflies, the natural world has provided invaluable tools that are transforming diagnostics and research.
The discussion kicks off with green fluorescent protein (GFP), a revolutionary biosensor derived from jellyfish. Discovered in the 1960s and popularized in the 1990s, GFP earned its place in history with a Nobel Prize. This remarkable protein fluoresces when exposed to specific wavelengths of light, enabling scientists to monitor cellular activities. GFP has become an indispensable tool for tracking cellular processes, from observing metabolic activities to measuring changes in pH levels. Joris shares an example from his PhD research, where he utilized a modified GFP to measure the redox state of cells, highlighting the protein’s adaptability and utility.
The conversation shifts to luminescence, drawing inspiration from fireflies and their ability to emit light through biochemical reactions. This phenomenon, known as bioluminescence, has been harnessed in medical research to create biosensors that can emit light when specific chemical reactions occur. Joris discusses how luminescent molecules, such as luciferase, have played pivotal roles in cancer research and diagnostics. A newer innovation, NanoLuc, inspired by deep-sea shrimp, has taken luminescence to the next level with its smaller, brighter design, enabling more efficient and precise applications.
This episode highlights how the interplay of biology and engineering continues to unlock new possibilities in diagnostics and medical devices. By mimicking nature’s ingenuity, biosensors are paving the way for non-invasive, accurate, and efficient tools for understanding and monitoring health.
How Nature-Inspired Biosensors Are Revolutionizing Medical Devices
Related Resources

Nick Allan and Nigel Syrotuck explain how a fluorescent protein assay helps engineers measure contamination and cleaning performance in medical devices.

Your team is ready for design validation. The prototype performs well, test plans are in motion, and everything points to a smooth handoff to manufacturing. Then your partner calls with bad news: they can’t build the device as designed.

You’ve cleared the toughest engineering hurdles and proven your design works. Then, just as you prepare to scale, your contract manufacturer turns you down.

In Medtech, a successful exit isn’t just about having an innovative device, it’s about building a business that potential buyers and investors can clearly see a future in.